Identification of patent foramen ovale permitting paradoxic embolism
- PMID: 7560596
- DOI: 10.1016/0735-1097(95)00288-9
Identification of patent foramen ovale permitting paradoxic embolism
Abstract
Objectives: We sought to analyze the morphologic and functional characteristics of the patent foramen ovale in patients with different clinical likelihoods for paradoxic embolism.
Background: The incidence of patent foramen ovale is increased in patients with otherwise unexplained arterial ischemic events. Because signs of venous thrombosis are absent in most patients, the diagnosis of paradoxic embolism is often questioned, even when patent foramen ovale is the only potential explanation for the ischemic event.
Methods: Seventy-eight patients with a patent foramen ovale detected by contrast transesophageal echocardiography were studied: 21 patients with an otherwise unexplained arterial ischemic event and clinical evidence implying paradoxic embolism (group I), 30 patients with an unexplained ischemic event but no clinical evidence for paradoxic embolism (group II) and 27 patients without an ischemic event (group III).
Results: During transesophageal contrast echocardiography, patients in group I had more severe right to left shunting (mean +/- SD 52 +/- 16% of the left atrial area filled with contrast medium) and a wider opening of the patent foramen ovale (7.1 +/- 3.6-mm separation between the septum primum and the septum secundum) than did patients in group II (35 +/- 15% and 4.4 +/- 3.2 mm, respectively, p < 0.001) or group III (23 +/- 12% and 3.0 +/- 2.0 mm, respectively, p < 0.001). The incidence of atrial septal aneurysm was similar in the three groups. Severe contrast shunting (> or = 50% of the left atrial area filled with contrast medium) and wide opening of the patent foramen ovale (> or = 5-mm separation) revealed a high sensitivity (71% and 86%, respectively) and high specificity (86% and 96%, respectively) for identification of group I patients.
Conclusions: Right to left contrast shunting is more severe and opening of the patent foramen ovale is larger in patients with ischemic arterial events considered to be due to paradoxic embolism. In patients with a patent foramen ovale as the only potential cause for ischemic events and no signs of venous thrombosis, morphologic and functional variables assessed by transesophageal echocardiography may be helpful in estimating the likelihood of paradoxic embolism.
Comment in
-
Identification of patent foramen ovale permitting paradoxic embolism.J Am Coll Cardiol. 1996 Jun;27(7):1817. doi: 10.1016/0735-1097(96)83798-3. J Am Coll Cardiol. 1996. PMID: 8636573 No abstract available.
Similar articles
-
Transesophageal echocardiographic diagnosis of right to left shunting across the foramen ovale in adults without prior stroke.J Am Coll Cardiol. 1993 Apr;21(5):1231-7. doi: 10.1016/0735-1097(93)90251-u. J Am Coll Cardiol. 1993. PMID: 8459082
-
Detection of right to left shunting through a patent foramen ovale in Japanese patients with ischemic stroke by transesophageal echocardiography using a standardized Valsalva maneuver.Tokai J Exp Clin Med. 2005 Dec;30(4):211-6. Tokai J Exp Clin Med. 2005. PMID: 16482941
-
Significance of left-sided heart disease for the detection of patent foramen ovale by transesophageal contrast echocardiography.J Am Coll Cardiol. 1992 May;19(6):1192-6. doi: 10.1016/0735-1097(92)90323-f. J Am Coll Cardiol. 1992. PMID: 1564219
-
Transcatheter closure of patent foramen ovale after presumed paradoxical embolism.Circulation. 1992 Dec;86(6):1902-8. doi: 10.1161/01.cir.86.6.1902. Circulation. 1992. PMID: 1451261 Review.
-
[Right-left auricular shunt caused by patent foramen ovale at a multi-purpose intensive care unit. Apropos of 3 cases].Agressologie. 1989 Jan;30(1):33-7. Agressologie. 1989. PMID: 2660615 Review. French.
Cited by
-
Current role of contrast echocardiography in the diagnosis of cardiovascular diseases.Clin Cardiol. 1997 Oct;20(10 Suppl 1):I31-8. doi: 10.1002/clc.4960201308. Clin Cardiol. 1997. PMID: 9383600 Free PMC article.
-
Transcatheter closure of patent foramen ovale using the Amplatzer septal occluder to prevent recurrence of neurological decompression illness in divers.Heart. 1999 Mar;81(3):257-61. doi: 10.1136/hrt.81.3.257. Heart. 1999. PMID: 10026348 Free PMC article.
-
Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis.Eur Heart J. 2015 Sep 14;36(35):2381-9. doi: 10.1093/eurheartj/ehv252. Epub 2015 Jul 3. Eur Heart J. 2015. PMID: 26141397 Free PMC article. Review.
-
Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence.Stroke. 2012 Feb;43(2):422-31. doi: 10.1161/STROKEAHA.111.631648. Epub 2011 Dec 15. Stroke. 2012. PMID: 22180252 Free PMC article.
-
Patent Foramen Ovale and Stroke.Curr Treat Options Cardiovasc Med. 2003 Jul;5(3):233-240. doi: 10.1007/s11936-003-0007-y. Curr Treat Options Cardiovasc Med. 2003. PMID: 12777201
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical